Biotech call – September 2026

Austrian funding agency, FFG, funds R&D costs for startups, small companies, medium-sized companies, large companies, research organisations, and universities participating in this call. Funding is available as a grant.

The amount of funding available depends on the type of organisation applying.

Additional eligibility criteria for applications from Austria

Funding for Austrian project partners is provided through FFG General Programme which offers improved funding conditions for Eureka projects. In Austria, all companies are eligible to apply to FFG General Programme, with cooperation opportunities for universities and research institutions.

Additional evaluation steps for applications from Austria

National applications in Austria are assessed and evaluated by experts from FFG. The final overall assessment in Austria, taking all criteria into account, is carried out by the advisory board of FFG General Programmes.

Additional steps for applications from Austria

Applicants in Austria must submit their application on the FFG eCall portal before 28 September 2026, 17:00 hours CEST. Funding in Austria is provided on an annual basis only, therefore follow-on applications must be submitted for the max. duration of 3 years. 

More information is available on the website of FFG.

Flemish funding agency, VLAIO, funds R&D costs for SMEs and large companies participating in this call. Funding is available as a grant.

Staff and other costs related to the development project can be funded with a 25% to 60% subsidy of the project budget, with eligible projects receiving a subsidy of between 25,000 euros and 500,000 euros.

Staff and other costs related to the research project can be funded with a 25% to 70% subsidy of the project budget, with eligible projects receiving a subsidy of between 100,000 euros and 500,000 euros.

In Belgium (Flanders), in addition to the centrally submitted Eureka Project Application Form, partners from Flanders need to submit a full application to VLAIO, including a project plan and budget online via either the VLAIO website for development projects or the VLAIO website for research projects.

Flemish partners must contact VLAIO for an eligibility and a pre-check of their project ideas and get support by our team VLAIO advisors. The deadline for submission of the VLAIO application is on Friday, 9 October, 2026, 12:00 CET.

More information is available on the website of VLAIO.

Walloon funding agency, Service Public de Wallonie (SPW), funds R&D costs for SMEs, large companies, research organisations, and universities participating in this call. Funding is available as a grant. There is no fixed amount of funding per project.

The amount of funding available depends on the type of organisation applying.

Subcontracting possible up to 20% of the total research budget of participating Walloon companies to any type of entities, including universities and research organisations.

Additional steps for applications from Belgium (Wallonia)

For further information: Prior to submitting a proposal, an information meeting between the Walloon partners of the project and the officers responsible for the programme within SPW Recherche will be organised. A regional application must be submitted on the ONTIME platform for the same deadline as Eureka’s.

For more information, please visit the website of SPW.

Canadian funding agency, National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), funds R&D costs for SMEs participating in this call. Funding is restricted to specific categories, each with its own conditions and maximum rates: 80% for salaries costs, 50% for contractor fees, and 75% for international travel costs for employees. The total funding an individual Canadian SME may request is limited to 500,000 Canadian dollars over 12 to 36 months. In addition to the Canadian SME, additional Canadian organisations (research institutes, universities, research and technology organisations, large enterprises and other companies) may participate on a self‑funded basis or as subcontractors.  The amount of funding available depends on the type of organisation applying.

Additional steps for applications from Canada

Canadian SME applicants must complete the following steps to submit an application:

1. Register with NRC IRAP by 16 June 2026 on the NRC IRAP call for proposals announcement webpage to determine basic NRC IRAP eligibility and to request an Expression of Interest (EOI) form.
2. Complete and submit the EOI form to NRC IRAP by 30 June 2026. Canadian SME applicants are strongly encouraged to complete the EOI phase as early as possible so that NRC IRAP can confirm the firm’s potential eligibility for funding before a full proposal is assembled and submitted.
3. Qualified Canadian SME applicants will be invited to submit the more detailed Eureka Network Projects proposal and draft consortium agreement in collaboration with their project partner(s). Qualified Canadian SME applicants will also receive an NRC IRAP Canadian SME Annex form, which must be completed alongside the Eureka Network projects proposal. For national requirements and further information of funding, eligibility and evaluation criteria Canadian applicants are asked to refer to the NRC IRAP call for proposals announcement webpage.

For more information, please visit the NRC IRAP call for proposals announcement webpage.

Chilean economic development agency, Corfo, funds R&D costs for SMEs and large companies participating in this call. Funding is available as a matching grant to a maximum of approximately 220,000 euros (220 million Chilean pesos).

The amount of funding available depends on the type of organisation applying.

An extra 10% funding is available for female-led companies.

Additional steps for applications from Chile

All interested companies from Chile must contact Corfo via innovacionempresarial@corfo.cl before applying to receive guidance from Corfo’s technical team.

The application process for this call has two stages:

Stage 1: International stage, in which project applications are submitted through the Eureka SmartSimple system.

Stage 2: National stage, in which Chilean companies with projects regarded as eligible in the international stage may apply for funding from Corfo.

Additional eligibility criteria for applications from Chile

Companies must be at least 24 months old at the time the national funding application is submitted. Universities and research organisations are not eligible to receive funding directly from Corfo but may participate as project collaborators.

Estonian funding agency, the Estonian Business and Innovation Agency (EIS), funds R&D costs for SMEs and large companies participating in this call. Funding is available as a grant. There is a maximum funding of 500,000 euros per project.

The amount of funding available depends on the type of organisation applying.

Additional steps for applications from Estonia

To receive EIS funding, a company that has received a positive decision must meet the following conditions:

• The company is an enterprise registered in Estonia
• The company is not an undertaking in difficulty
• The company has the necessary resources to cover the self-financing of the project
• The company has a significant impact on the Estonian economy

The following components are generally considered in terms of impact on the Estonian economy:

• Location of jobs
• Location of production
• Location of development activities
• Location of IO
• Location of sales revenue

In addition, EIS looks at the overall picture, how the company’s economic activities and the added value generated by them are related to Estonia.

For more information, please visit the website of EIS.

French funding agency, Bpifrance, funds R&D costs for startups and SMEs participating in this call.

Funding is available as a loan. The amount of funding available depends on the type of organisation applying.

Companies with more than 2,000 full-time equivalent employees are not eligible for funding but can self-fund their project costs. Research organisations and universities are not eligible for funding but can participate as subcontractors.

Additional eligibility criteria for applications from France

The project and the French firm’s technical and financial capacity to carry it through must be assessed by Bpifrance.

Additional evaluation steps for applications from France

In order to check their eligibility, French participants must contact their Bpifrance chargé(e) d’affaires innovation, prior to applying. Then, the national funding application must be submitted on the Bpifrance En Ligne platform before 25 September 2026. The Bpifrance en Ligne account will be opened with the help of the chargé(e) d’affaires innovation.

Additional steps for applications from France

Before applying, you must contact your Chargé(e) d’Affaires Innovation in your Bpifrance Regional Office to discuss the application with them and verify your eligibility. Then, you will have to submit your national application (“demande d’aide à l’innovation“) on the Bpifrance En Ligne platform by 25 September 2026. You will have to submit financial and technical documents requested by your chargé(e) d’affaires innovation.

German funding is provided by the Federal Ministry for Research, Technology and Space (BMFTR) under the High-tech Agenda for Germany and the National Strategy for Bio-economy via the framework initiative on future technologies for industrial bio-economy (Rahmenbekanntmachung: Zukunftstechnologien für die industrielle Bioökonomie), which is the legally binding document for any decision on the eligibility of applicants and the national application process („Vorlage förmlicher Förderanträge und Entscheidungsverfahren“).

German Applicants are strongly recommended to refer to the “Rahmenbekanntmachung: Zukunftstechnologien für die industrielle Bioökonomie” and the “Europäische Zusammenarbeit in der industriellen Biotechnologie – Eureka Biotech-Call for Network Projects” where all national requirements for funding are defined.

Eligible topics include (non-exhaustive list):

• Development of sustainable biotechnological production processes using renewable carbon sources (e.g. biogenic residues, CO₂, secondary raw materials),
• Biotechnological production of platform and fine chemicals as substitutes for fossil-based products,
• Process development for the biotechnological production of ingredients and additives as well as innovative biofunctionalized products,
• Development of novel foods through precision fermentation or the cultivation of animal cells.

Projects involving medical or pharmaceutical applications (red biotechnology) are not eligible for funding.

Participants from Germany can receive a grant of up to 500,000 euros, including project lump sum (Projektpauschale) if applicable.

Projects that are eligible for funding are exclusively those with a significant SME-contribution in Germany. Non-profit partners may join the consortia when appropriate. Project consortia without SME contribution are not eligible. In order to ensure a balanced co-operation within the consortia, project contribution from one country may not exceed 70% of the entire project costs.

German applicants who are eligible to receive the project lump sum (Projektpauschale) must make sure, that this is outlined in the proposal. More information on who is eligible to receive the project lump sum is included in the “Rahmenbekanntmachung: Zukunftstechnologien für die industrielle Bioökonomie”.

• German funding is based on §§23 and 44 BHO (“Bundeshaushaltsordnung”) and associated administrative regulations. The main items are as follows:
• The procedure (“Verfahren”) is according to the above-mentioned protocol (“Rahmenbekanntmachung, see Chapter “Application Procedure”). Funding will be awarded as non-repayable project grant.
• All funding regulations, follow up and reporting of publicly funded projects are regulated according to the “Rahmenbekanntmachung: Zukunftstechnologien für die industrielle Bioökonomie” and NKBF 2017, NABF and BNBest-mittelbarer Abruf-BMFTR, respectively.
• Research institutions, which receive basic financing, can be funded subject to specific conditions.

The application follows a two-step process:

1. Submission of a Eureka proposal via Eureka portal: A general eligibility check on Eureka level and the scientific/technological evaluation is conducted on the base of the Eureka proposal.
2. Submission of a national funding application via easy-Online: The legally binding national funding decision (Förderbescheid) is based on the national funding application (Förderantrag nach AZA, AZK, AZV).

Prior to the application, German applicants are encouraged to contact the German Eureka office:

• German Eureka office, +49 228 3821-1050, eureka.npc@dlr.de

For thematic questions, German applicants are invited to contact the national contact point at Projektträger Jülich:

• Dr. Christian Breuer, +49 2461/61-96929, c.breuer@ptj.de
• Dr. Josefine Kant, +49 2461/61-84689, j.kant@ptj.de
• Dr. Petra Schulte, +49 2461/61-9031, petra.schulte@ptj.de
• Dr. Ines Sender, +49 02461/61-9714, i.sender@ptj.de

Lithuanian funding agency, the Research Council of Lithuania (RCL), funds R&D costs for SMEs, research organisations, and universities participating in this call. Funding is available as a grant. The total maximum funding budget per project is 300,000 euros.

The amount of funding available depends on the type of organisation applying.

RCL funds joint research-business projects. Applications must be submitted by the research institution with a mandatory partner – SME.

Additional eligibility criteria for applications from Lithuania

RCL funds TRL 5-9, so TRL 4 must be achieved. RCL evaluates not only the international project but also the national application in order to evaluate Lithuanian participants activities in the project.

The Netherlands scope requirements

To be eligible for funding in the Netherlands, projects must align with the following scope: Advancing Innovative Therapies and Organ-on-Chip Technologies. In this call, the Netherlands specifically focuses on advancing innovative cell and gene therapies (CGT) and Organ-on-Chip (OoC) technologies, with the goal of accelerating the translation of research into practical applications. Projects may focus on the development of novel CGT therapies, the development and improvement of OoC technologies for diverse applications, or a combination of both.

Please note: Other topics outside of these areas will not be considered for funding.

Cell and Gene Therapy (CGT) projects

For CGT projects, the focus is on translational research and clinical development (TRL 4-7) of cell and gene therapies. Projects should aim to bridge the gap between early-stage research and clinical application, with an emphasis on making therapies clinically effective, scalable, sustainable, and affordable. Proposals may address key challenges in CGT through the development of technically innovative solutions to overcome bottlenecks in, for example, manufacturing, delivery, regulatory approval, or cost-effectiveness. The goal is to accelerate the development of CGT solutions, ensuring faster market entry, broader patient access, and sustained cost-effectiveness.

Organ-on-Chip (OoC) projects

For OoC projects, the focus is on the development of organ-on-chip models and their translation into practical applications (TRL 4-7). Projects may address key challenges in the further development and validation of these models, through the development of technically innovative solutions to overcome bottlenecks in for example standardisation, scalability, or application. Proposals should demonstrate the feasibility and potential of OoC technologies for disease modeling, toxicity testing, and therapeutic evaluation, with the goal of supporting their wider adoption in preclinical research and drug development.

The Netherlands consortium requirements

To be eligible for funding in the Netherlands, a public-private project consortium must include at least two independent partners from the Netherlands: one research organisation and one for-profit enterprise, as well as two independent partners from a Heath Holland priority country: one research organisation and one (for-profit) enterprise.

Health Holland priority countries participating in this biotech-call are Belgium, France, Germany, Singapore, Spain, Sweden, and Switzerland (See Annex II: Target countries, Health Holland International Strategy 2024-2027).

Organisations from non-priority countries are welcome to join if the consortium criterion is met and (public or self-) funding is secured by the call deadline.

The Netherlands funding rules

Dutch project partners may apply for a minimum of 400,000 euros and a maximum of 750,000 euros in PPP subsidy. Within this call, Dutch research organisations and Dutch SMEs are eligible to apply for funding for their R&D project costs. The specific conditions for the allocation and use of the PPP subsidy vary according to the type of organisation and are outlined below (Table 1).

Dutch research organisations

Research organisations, such as universities, UMCs, universities of applied sciences, TO2s, KNAW institutes, and other organisations that meet the definition of a research organisation, may fund up to 70% of their own costs with PPP subsidy in the case of industrial research. For experimental development, research organisations may fund up to 60% of their own costs using the PPP subsidy.

Dutch SMEs

Dutch SMEs may fund up to 60% of their own costs using the PPP subsidy for industrial research. For experimental development, Dutch SMEs may fund up to 40% of their own costs with PPP subsidy. If a Dutch SME wishes to apply for the PPS subsidy, they must submit a signed ‘verklaring geen onderneming in moeilijkheden’ (OiM) along with their application.

Other parties

Dutch large enterprises, Dutch undertakings in difficulty (OiM), Dutch other parties, and all foreign parties are not eligible for PPP subsidy.

Table 1: Funding per type of research – Partner level 

Minimum required cofinancing

Table 2 shows the minimum percentage of total project costs that must be contributed by the research organisation(s) and enterprise(s) in the project. These minimum contributions refer to the combined contribution of all organisations of the same type within the consortium.

Table 2: Minimal contributions – Project level

Undertaking in Difficulty (OiM)

For all state aid subsidies, including the PPP regulation, a company may only receive a PPP subsidy if it does not qualify as an Undertaking in Difficulty (OiM) according to the applicable definition. Accordingly, it is mandatory for all companies applying for PPP subsidy to submit a “Declaration of non-Undertaking in Difficulty”, or ‘verklaring geen onderneming in moeilijkheden’ accompanied by the completed decision tree, and where applicable, the organisational chart of the affiliated group, clearly indicating the shareholding structure and ownership relationships. The definition of OiM, declaration, and the decision tree can be found on the RVO website..

Other Dutch eligibility criteria

• The project contributes to the (further) development of one or more of the ten priority key technologies identified in the National Technology Strategy, thereby aligning with the Dutch Growth markets. 
• The R&D project fits within the Dutch societal challenge ‘Health & Care’, as outlined in the Knowledge and Innovation Agenda (KIA) 2024-2027.
• In the project activities, there must be a technological risk involved (industrial research and/or experimental development – TRL4-TRL7).
• The project must be directed at researching or developing a (set of) product(s), process(es) or service(s).
• The project must benefit all project partners in a well-balanced consortium, and the project is significant to the health strategies in countries involved.
• The project has an obvious advantage and added value resulting from the cooperation between the participants from the different countries (e.g. increased knowledge base, commercial leads, access to data, R&D infrastructure, etc.).
• The project must start between 1 January 2027, and 1 June 2027.
• The duration of the project may not exceed 36 months.
• All consortium partners must at least incur personnel costs, which must be visible in the budget form.
• In addition to the in-kind contribution, it is also possible to contribute in-cash. An in-cash contribution from one party must be used within the project to cover the costs of another consortium partner. Applying for PPP subsidy and making an in-cash contribution by the same party is not permitted.
• Consortium partners may not hire or compensate each other for services or products within the project. Consequently, consortium partners may not invoice each other. Third parties may be hired for services; they are not consortium partners.
• Collected and/or generated data should comply with the FAIR principles. Data and code used and/or developed in the project should be shared and accessible for all consortium partners. A data management and stewardship plan is mandatory (drawn up if the application is awarded for funding).
• A signed consortium agreement on the execution of the project and the commercialization of the project results is mandatory before the start of the project using the model consortium agreement, made available by Health Holland for this Eureka Biotech call. This consortium agreement includes, amongst others, the ownership and use of the know-how and IP agreements.

Steps for applications from the Netherlands

In addition to the centrally submitted online Eureka project application form, Dutch participants of the international project consortium must submit the required national documents. More details and the required documentation can be found on the website of RVO and Health Holland.

Dutch participants that require funding from Health Holland are recommended to get in touch with RVO and Health Holland contact persons before submitting the application.

Contact details

• Netherlands Enterprise Agency (RVO) (www.rvo.nl/eureka)
• Call management: Niels van Leeuwen – niels.vanleeuwen@rvo.nl or teamiris@rvo.nl
• Health Holland (EUREKA Biotech call 2026)
• Call management: Jolande Zijlstra, Annebel Hendrix, Daan Dolfing – tki@health-holland.com

Singaporean funding agency, Enterprise Singapore (Enterprise SG), funds R&D costs for SMEs and large companies participating in this call. Funding is available as a grant. There is no total maximum funding budget per project.

The amount of funding available depends on the type of organisation applying.

Research organisation or university

Research organisations or university Institutes of Higher Learning (IHLs) and research institutions (RIs) can only be funded as a subcontractor to a private enterprise.

Additional steps for applications from Singapore

Companies must submit an application on the Business Grant Portal. The application instructions will be given upon prior consultation with an Enterprise Singapore representative.

Additional eligibility criteria for applications from Singapore

Applicant companies must be:

In a financially viable position to start and complete the project. The lead applicant should be a business entity that is registered/incorporated and operating in Singapore.

Locally owned (the applicant should have at least 30% of its ordinary shares held directly or indirectly by Singaporeans/Singapore PRs) 

South African funding agency, the Department of Science, Technology and Innovation (DSTI), funds R&D costs for SMEs, large companies, research organisations, and universities participating in this call. The total national budget is 50% of the applicants’ budget request to the National Funding Body.

The amount of funding available depends on the type of organisation applying.

Additional steps for applications from South Africa

Applicants must approach the National Funding body at least 30 days prior to the submission deadline of project call.

Additional eligibility criteria for applications from South Africa

The South African Decadal Plan priorities and socio-economic challenges must be addressed in the project.

South Korean funding agency, Korea Institute for Advancement of Technology (Kiat), funds R&D costs for SMEs, large companies, research organisations, and universities participating in this call. Funding is available as a grant. The total national budget is 1.8 million euro. Maximum funding per project is a grant of up to 500 million South Korean won (approximately 300,000 euro) per year, for up to three years.

The amount of funding available depends on the type of organisation applying.

Please refer to the national call text on the website of KIAT.

Additional eligibility criteria for applications from South Korea

At least one Korean company (private) should be included in the Korean consortium. All participating Korean companies must have been in business for more than one year as of the date indicated on the business registration certificate. All participating Korean companies should have obtained the “Corporate R&D Centre Accreditation” issued by KOITA (Korea Industrial Technology Association). Project funding is comprised of government contribution (grants) and civilian dues (cash and in-kind)

Spanish funding agency, Centre for Technology Development and Innovation (CDTI), funds R&D costs for SMEs and large companies participating in this call. Funding is available as a loan. There is no maximum amount of funding per project.

The amount of funding available depends on the type of organisation applying.

The minimum budget for each company is 175,000 euro. There is no budget limitation for Spanish partners, but budget must be in concordance with the activities to be developed and the capacity of the company.

A list of R&D projects of International Technological Cooperation can be found on the website of CDTI.

The Spanish company (or the Spanish consortium coordinator, where applicable) shall submit a formal application for international R&D project funding through CDTI’s electronic office by 2 October 2026. The application shall include the Eureka Application Form (in English) and, where available, a draft consortium agreement. The signed consortium agreement shall be submitted prior to the endorsement of the Eureka label.

Upon receipt of the international application, CDTI shall verify the eligibility of the Spanish applicants. If deemed eligible, CDTI shall enable the corresponding national funding applications for each Spanish participant. These applications shall be duly completed and submitted by all Spanish partners within the deadline established by CDTI, approximately one month after the call deadline.

Depending on the funding instrument requested, CDTI may require the submission of additional documentation in Spanish. Spanish partners that fail to submit the required applications within the established deadlines may be withdrawn.

Research organisation or university

Universities and research centres could take part as subcontractors.

Swedish funding agency, Vinnova funds R&D costs for SMEs, large companies, research organisations, and universities participating in this call. Funding is available as a grant. The total national budget is 556,457 euro. Maximum funding per project is 278,228 euro.

The amount of funding available depends on the type of organisation applying.

Additional steps for applications from Sweden

Prior to the project start, all Swedish participants, including the assigned Swedish coordinator, must fill in the form “Participant Approval.” All project participants in the international Eureka project shall enter into a Consortium Agreement. The Consortium Agreement shall include the Participants’ mutual commitments, conditions concerning rights to foreground and background information and other issues of significance to the cooperation. The participants shall have entered into the Consortium Agreement no later than the date when the first Vinnova status report is due.

Additional eligibility criteria for applications from Sweden

At least one Swedish company must be part of the international project consortium.

Swedish participants can apply for grants according to Vinnova’s general terms and conditions for grants. State aid rules apply to organisations that carry out economic activities. The rules on state aid for research, development and innovation are stated in the European Commission’s General Block Exemption Regulation No 651/2014 (GBER). In this call article 25 in GBER applies, with support for Industrial research.

Swedish participants that require funding from Vinnova are recommended to get in touch with the Vinnova contact person before submitting the national application.

In addition to the centrally submitted online Eureka project application form, Swedish participants of the international project consortium apply on the Vinnova website to the national call that opens on 31 March 2026 and closes on 30 September 2026 at 14:00 CEST.

The complete Eureka application form of the international project consortium, including all partner forms, project budget and a Gantt diagram of work packages, must be submitted as the project description in the application to Vinnova. A CV for the Swedish project coordinator should also be submitted as an appendix to the application.

Swiss funding agency, Innosuisse, funds R&D costs for SMEs, large companies, research organisations, and universities participating in this call. Funding is available as a grant and covers a maximum of 70% of the Swiss project costs.

The amount of funding available depends on the type of organisation applying.

Additional steps for applications from Switzerland

Swiss partners apply for funding via the Innosuisse portal, selecting the keyword “Eureka”, until 25 September 2026.

Additional eligibility criteria for applications from Switzerland

• Applications submitted to Eurostars Call 11 in parallel are not eligible.
• At least one research partner, from Switzerland or abroad, must be part of the consortium.
• Participation of partners downstream in the value-chain (e.g. system integrators, distributors, etc.) is encouraged to strengthen the implementation plan.
• Companies must provide evidence about the stability of their financial situation (templates downloadable).

Guidelines for submitting an application are also available on the website of Innosuisse.

Turkish funding agency, TÜBİTAK, funds R&D costs for SMEs, large companies, research organisations, and universities participating in this call. Funding is available as a grant. The total national budget is 2.5 million euro. Maximum funding per project is 500,000 euro.

The amount of funding available depends on the type of organisation applying.

Additional steps for applications from Türkiye

In addition to the Eureka application steps, applicants in Türkiye must complete the following national procedures:

• Applicants must submit a national application to TÜBİTAK.
• Applications must be completed through the TÜBİTAK PRODİS system.
• The national application must be submitted within the deadlines specified in the national call schedule.
• If more than one Turkish partner is involved, a single joint national application must be submitted.
• Applicants may be required to provide detailed project information, budget breakdowns, and supporting documents in line with TÜBİTAK requirements.

In addition to the Eureka evaluation, proposals undergo a national evaluation by TÜBİTAK.

Projects are assessed through external expert (referee) reviews, including on-site visits, followed by a decision by the relevant evaluation committee. Evaluation focuses on three main dimensions:

1. industrial R&D content, technological level, and innovation,
2. feasibility of the project plan and adequacy of the applicant’s infrastructure,
3. potential for economic impact and national benefit.

Projects may be rejected if critical issues are identified, such as: lack of genuine R&D content, completed R&D prior to application, unrealistic or misaligned budget, insufficient technical capacity/personnel, low feasibility or commercialisation potential, or non-compliance with call requirements.

Additional eligibility criteria for applications from Türkiye

Budget Limits: The total call budget is €2.5M; max €500k per project for Turkish partners. Non-company institutions can receive up to 30% of the total budget.

Eligible Costs: Personnel, travel, consultancy, subcontracting/services, equipment/software, and consumables. Universities/public bodies may also include institutional overhead and project incentives.

Subcontracting: Allowed, but not between consortium partners.

Eligibility & Consortium: Applicants include companies, universities, research institutes, and research hospitals. Universities/public bodies cannot apply alone; at least one company must act as coordinator. Turkish partners in the same project must submit a single joint national application.

Application: Requires submission to the Eureka call and a mandatory national application via TÜBİTAK PRODİS.